Rana R McKay

92PUBLICATIONS
596CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Systems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Aug 05, 2026
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|Jul 01, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

|Jun 19, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

|Jun 03, 2026
Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

Pageof 16

Frequent Collaborators

15 joint publications

Elisabeth I Heath

14 joint publications

Andrew J Armstrong

13 joint publications

Toni K Choueiri

12 joint publications

Emmanuel S Antonarakis